CO4600675A1 - Derivados de oxalilamino-benzofurano y benzotienilo - Google Patents

Derivados de oxalilamino-benzofurano y benzotienilo

Info

Publication number
CO4600675A1
CO4600675A1 CO95023181A CO95023181A CO4600675A1 CO 4600675 A1 CO4600675 A1 CO 4600675A1 CO 95023181 A CO95023181 A CO 95023181A CO 95023181 A CO95023181 A CO 95023181A CO 4600675 A1 CO4600675 A1 CO 4600675A1
Authority
CO
Colombia
Prior art keywords
carbon atoms
straight
branched chain
halogen
series
Prior art date
Application number
CO95023181A
Other languages
English (en)
Inventor
Gabriele Braunlich
Rudiger Fischer
Mazen Es Sayed
Rudolf Hanko
Stephen Tudhope
Graham Sturton
Abram Trevor
Wendy J Mcdonald-Gib
Mary F Fitzgerald
Original Assignee
Gabriele Braunlich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9410863A external-priority patent/GB9410863D0/en
Priority claimed from GB9410891A external-priority patent/GB9410891D0/en
Application filed by Gabriele Braunlich filed Critical Gabriele Braunlich
Publication of CO4600675A1 publication Critical patent/CO4600675A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Materials For Photolithography (AREA)
  • Indole Compounds (AREA)
  • Manufacturing Optical Record Carriers (AREA)
  • Medicinal Preparation (AREA)

Abstract

Derivados de oxalilamino-benzofurano y benzotienilo de fórmula general (I):en la cualL representa un átomo de oxígeno o azufre.R1 representa hidrógeno o alquilo de cadena lineal o ramificada que tiene hasta 6 átomos de carbono o representa halógeno, carboxilo, ciano, nitro, trifluorometilo o un grupo de fórmula -OR5 , -SR6 o -NR7 R8 ,en las cualesR5 , R6 y R8 son iguales o diferentes o indican hidrógeno, cicloalquilo que tienen 3 a 6 átomos de carbono, bencilo o un heterociclo tiene hasta 3 heteroátomos de la serie que comprende N, S y O y con el que puede estar condensado un anillo fenilo y que está opcionalmente sustituidos con sustituyentes iguales o diferentes de la serie que comprende halógeno, ciano, nitro o con un grupo alquilo de cadena lineal o ramificada que tiene hasta 6 átomos de carbono, o indica alquilo o alquenilo de cadena lineal o ramificada que tienen cada uno hasta 8 átomos de carbono, o indica fenilo, que esta opcionalmente monosustituido a disustituido con sustituyentes iguales o diferentes de la serie que comprende nitro, halógeno, carboxi; o alcoxicarbonilo de cadena lineal o ramificada que tiene hasta 6 átomos de carbono,oR5 indica un grupo protector de hidroxilo, y R7 indica hidrógeno o un grupo alquilo de cadena lineal o ramificada que tiene hasta 4 átomos de carbono, R2 representa hidrógeno o alquilo de cadena lineal o ramificada que tiene hasta 6 átomos de carbono,R3 representa hidroxilo, benciloxi o alquilo o alcoxi de cadena lineal o ramificada que tiene cada uno hasta 10 átomos de carbono, y cada uno de los cuales está opcionalmente monosustituido a trisustituido con sustituyentes iguales o diferentes de la serie que comprende halógeno, carboxilo, trifluorometilo, fenilo, ciano o alcoxi u oriacilo de cadena lineal o ramificada que tienen cada uno hasta 6 átomos de carbono, morfolinilo...
CO95023181A 1994-05-31 1995-05-30 Derivados de oxalilamino-benzofurano y benzotienilo CO4600675A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9410863A GB9410863D0 (en) 1994-05-31 1994-05-31 Heterocyclycarbonyl substituted oxalylamino-benzofurane derivatives
GB9410891A GB9410891D0 (en) 1994-05-31 1994-05-31 Oxalylamino-benzofuran-and benzothienyl-derivatives

Publications (1)

Publication Number Publication Date
CO4600675A1 true CO4600675A1 (es) 1998-05-08

Family

ID=26304969

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95023181A CO4600675A1 (es) 1994-05-31 1995-05-30 Derivados de oxalilamino-benzofurano y benzotienilo

Country Status (29)

Country Link
US (1) US5565488A (es)
EP (1) EP0685474B1 (es)
JP (1) JPH083154A (es)
KR (1) KR950032163A (es)
CN (1) CN1119187A (es)
AT (1) ATE171172T1 (es)
AU (1) AU695464B2 (es)
BG (1) BG99680A (es)
CA (1) CA2150301A1 (es)
CO (1) CO4600675A1 (es)
CZ (1) CZ140895A3 (es)
DE (1) DE69504753T2 (es)
DK (1) DK0685474T3 (es)
EE (1) EE9500034A (es)
ES (1) ES2124461T3 (es)
FI (1) FI952612A (es)
HR (1) HRP950288A2 (es)
HU (1) HUT71597A (es)
IL (1) IL113894A (es)
LV (1) LV11467B (es)
MA (1) MA23603A1 (es)
MY (1) MY130580A (es)
NO (1) NO952129L (es)
NZ (1) NZ272217A (es)
PL (1) PL308825A1 (es)
RO (1) RO113642B1 (es)
SK (1) SK72195A3 (es)
TN (1) TNSN95061A1 (es)
ZA (1) ZA954400B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
GB9614718D0 (en) 1996-07-12 1996-09-04 Bayer Ag 3-ureido-pyridofurans and -pyridothiophenes
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
KR100701904B1 (ko) 1999-08-21 2007-04-02 알타나 파마 아게 Ｐｄｅ 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합
US7144885B2 (en) 2002-02-22 2006-12-05 Bayer Pharmaceuticals Corporation Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
US7351735B2 (en) * 2002-02-22 2008-04-01 Bayer Pharmaceuticals Corporation Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
BRPI0410940A (pt) * 2003-06-05 2006-08-29 Warner Lambert Co benzo[b]tiofenos substituìdos com cicloalquilsulfanila como agentes terapêuticos
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
CA2527573A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
EP1644360A1 (en) * 2003-06-05 2006-04-12 Warner-Lambert Company LLC 3-substituted indoles and derivatives thereof as therapeutic agents
MXPA05012894A (es) * 2003-06-05 2006-02-22 Warner Lambert Co Benzofuranos 3-sustituidos como agentes terapeuticos.
WO2004108716A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents
US7576122B2 (en) * 2003-09-02 2009-08-18 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
WO2008025509A1 (en) * 2006-09-01 2008-03-06 Bayer Schering Pharma Aktiengesellschaft Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
KR101881596B1 (ko) 2008-12-02 2018-07-24 웨이브 라이프 사이언시스 재팬 인코포레이티드 인 원자 변형된 핵산의 합성 방법
SG10201403841QA (en) 2009-07-06 2014-09-26 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6128529B2 (ja) 2011-07-19 2017-05-17 ウェイブ ライフ サイエンシズ リミテッドＷａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｌｔｄ． 官能化核酸の合成のための方法
US9598458B2 (en) 2012-07-13 2017-03-21 Wave Life Sciences Japan, Inc. Asymmetric auxiliary group
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
NZ717739A (en) 2013-08-09 2023-12-22 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
BR112016016400A2 (pt) 2014-01-16 2017-10-03 Wave Life Sciences Ltd Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146243A1 (en) 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
US5120742A (en) * 1984-02-27 1992-06-09 Merck & Co., Inc. 17 β-acyl-4-aza-5 α-androst-1-ene-3-ones as 5 α-reductase inhibitors
GB9200623D0 (en) * 1992-01-13 1992-03-11 Bayer Ag Benzofuranyl and thiophenyl-methylthio-alkanecarboxylic acid derivatives
GB9309324D0 (en) * 1993-05-06 1993-06-16 Bayer Ag Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives

Also Published As

Publication number Publication date
DE69504753D1 (de) 1998-10-22
AU695464B2 (en) 1998-08-13
CA2150301A1 (en) 1995-12-01
NZ272217A (en) 1997-02-24
MA23603A1 (fr) 1996-04-01
JPH083154A (ja) 1996-01-09
DK0685474T3 (da) 1999-06-14
CZ140895A3 (en) 1995-12-13
IL113894A (en) 1999-06-20
AU2028695A (en) 1995-12-07
BG99680A (en) 1996-01-31
LV11467A (lv) 1996-08-20
ZA954400B (en) 1996-01-24
DE69504753T2 (de) 1999-02-04
PL308825A1 (en) 1995-12-11
HUT71597A (en) 1996-01-29
EP0685474B1 (en) 1998-09-16
RO113642B1 (ro) 1998-09-30
KR950032163A (ko) 1995-12-20
CN1119187A (zh) 1996-03-27
EP0685474A1 (en) 1995-12-06
ATE171172T1 (de) 1998-10-15
EE9500034A (et) 1995-12-15
ES2124461T3 (es) 1999-02-01
LV11467B (en) 1996-12-20
SK72195A3 (en) 1995-12-06
MY130580A (en) 2007-06-29
IL113894A0 (en) 1995-08-31
TNSN95061A1 (fr) 1996-02-06
FI952612A0 (fi) 1995-05-29
HRP950288A2 (en) 1997-08-31
NO952129L (no) 1995-12-01
NO952129D0 (no) 1995-05-30
HU9501569D0 (en) 1995-07-28
FI952612A (fi) 1995-12-01
US5565488A (en) 1996-10-15

Similar Documents

Publication Publication Date Title
CO4600675A1 (es) Derivados de oxalilamino-benzofurano y benzotienilo
AR010331A1 (es) Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos.
ES2182535T3 (es) Derivados de benzo(b)tiepina-1,-dioxido, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
PE55098A1 (es) Derivados de 6-fenilpiridil-2-amina
CY1106867T1 (el) Οι ο-κυκλοπροπυλ καρβοξανιλιδες και η χρηση τους ως μυκητοκτονα
AR016131A1 (es) -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos.
CO5540391A2 (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibi dores de la fosfodiesterasa
CO4900062A1 (es) Piridinas condensadas con heterociclos
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
AR002710A1 (es) Derivados de n-(3-benzofuranil)urea, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, un procedimiento para preparardicha composicion farmaceutica y el uso de dichos derivados para la preparacion de medicamentos.
ES2140654T3 (es) 1,2,3,4-tetrahidro-5-nitro-pirimidinas substituidas.
AR247551A1 (es) Procedimiento para obtener derivados de 16-deshidro-vitamina d3
PA8483901A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida
ATE66240T1 (de) Phenolische korrosionsinhibitoren fuer anstrichstoffe.
CO4810231A1 (es) Nuevas sulfonamidas naftil- y anilido - substituidas
HUP0101132A2 (hu) Amidvegyületet tartalmazó, szinergetikus hatású fungicid hatóanyag keverék és alkalmazása
HUP9903720A2 (hu) Készítmény és eljárás káros gombák elleni védekezésre
DK288287A (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
MX9306529A (es) Derivados de pirazol condensado, metodo para fabricarlos y composicion farmaceutica que los contiene
DK144080A (da) Skadedyrsbekaempelsesmiddel
CO4761067A1 (es) Nuevas heteroalioxazolidinonas
ES2062088T3 (es) Agente para la proteccion de plantas contra enfermedades.
MX9302165A (es) Derivados de benzoxazinona y benzothiazinona y composiciones farmaceuticas que los comprende
AR008228A1 (es) Derivados aromaticos sustituidos con un radical de ribosa, su procedimiento de preparacion, compuestos intermediarios para su exclusivo uso en dicho procedimiento, medicamentos y composiciones farmaceuticas.
CO5261509A1 (es) Nuevos bis-benzimidazoles